The U.S. healthcare system, particularly physician practices and specialized providers, is preparing for 2026, which is shaping up to be a pivotal year. Beneath the surface of modest annual reimbursement updates, the Centers for Medicare & Medicaid Services (CMS) is implementing fundamental changes to the Medicare Physician Fee Schedule (PFS) while tightening payment rules across the board.

 

For healthcare real estate investors, these policy shifts matter because reimbursement directly underpins provider profitability, staffing decisions, service offerings, and ultimately a tenant’s ability to expand, contract, or remain in place long term. Medicare mechanics may feel abstract, but their downstream effects show up clearly in tenancy durability, credit quality, and real estate strategy.

 

These regulatory changes, combined with increasing pressure from Medicare Advantage (MA) plans and persistently rising operating costs, are compressing provider margins and making financial stability increasingly uncertain for many independent groups. The convergence of these forces points toward a future defined less by expansion and more by cost containment and balance-sheet discipline

 

2026 Physician Fee Schedule

The 2026 PFS includes a statutory 2.5% increase to the conversion factor, which is the base multiplier used to translate clinical services into Medicare dollars. Essentially, this establishes the starting point for what Medicare pays physicians per unit of work, so even small changes materially affect overall practice revenue. However, for many specialty providers, that headline increase will be offset by a new and controversial policy known as the efficiency adjustment.

 

The efficiency adjustment is a negative 2.5% offset applied to services CMS believes can now be delivered more efficiently, due to technology or workflow improvements. Effectively, Medicare is paying less per procedure on the assumption that providers can do more with fewer resources.

 

In practice, this policy primarily impacts procedure-driven specialties, such as surgery, imaging, and specialized outpatient care. The result is straightforward: many providers are paid less per procedure even as labor, supply, and compliance costs continue to rise.

From Revenue Gaps to Consolidation

CMS positions the change as a way to shift resources toward value-based care and strengthen primary care. Physician groups, including the American Medical Association, counter that it risks limiting patient access and undermining practice sustainability. These pressures are further amplified by additional reimbursement reductions for services performed in hospitals and ambulatory surgical centers, where many specialty procedures take place.

 

Industry projections suggest that some specialty practices, including oncology and Ob/Gyn groups, could experience effective reimbursement declines ranging from 10% to 20%. Operationally, reductions of this magnitude often translate into hiring freezes, reduced clinical hours, elimination of marginal service lines, or reconsideration of secondary locations. For real estate investors, these pressures can influence space utilization, renewal decisions, and expansion plans.

 

The rule also introduces two separate conversion factors: a slightly higher update (0.75%) for providers participating in advanced alternative payment models, and a lower update (0.25%) for those on the standard track. For many practices, this widens the revenue gap between groups that can absorb risk and those that cannot, accelerating consolidation pressure. While intended to encourage value-based care participation, this two-tier structure adds financial complexity and risk for groups still evaluating whether those models are viable.

 

Medicare Advantage Pullback Compounds Financial Pressure

Beyond traditional Medicare, providers are also facing mounting pressure from Medicare Advantage plans. Due to rising utilization (as patients use more services per member), escalating healthcare costs, and tighter regulatory scrutiny, several major insurers are scaling back their MA offerings for 2026.

 

For providers, this pullback creates instability on multiple fronts. Insurers may exit certain counties altogether, forcing patients to change plans and disrupting established referral relationships. Remaining plans are increasingly narrowing networks, reducing covered services, or tightening prior authorization requirements.

 

For investors, this manifests as volatility in patient traffic, less predictable referral flows, and heightened risk for specialty-heavy tenants whose volumes depend on managed-care approvals. Reduced access or coverage changes can quickly lead to underutilized space, especially in procedure-driven specialties.

 

Because specialty utilization is closely tied to MA plan design and approvals, the pullback affects both reimbursement rates and patient volumes at the same time. This compounds the financial stress already created by changes to the PFS, making revenue forecasting more difficult and leading to slower expansion, greater hesitation around long-term lease commitments, and reduced visibility into future real estate needs.

 

Rising Compliance Workload: The Hidden Cost Center

One of the most significant but least visible financial pressures in the 2026 rules is the expanding administrative and compliance burden. CMS is intensifying oversight around payment accuracy and fraud prevention, effectively shifting a growing amount of uncompensated work onto providers.

 

For physician groups, this compliance burden functions much like operating expense inflation without any corresponding revenue increase. Staff time, IT upgrades, consulting support, and audit preparation all rise, but reimbursement does not.

 

A prominent example is CMS’ policy change regarding skin substitutes. After citing explosive growth in spending, CMS is revising how these products are reimbursed, with the goal of reducing Medicare expenditure by nearly $20 billion next year. Providers must rapidly adapt documentation and billing processes to comply with the new structure.

 

The rule also modifies quality reporting by adding five new outcome-focused measures, while removing ten that deemed ineffective. While this is positioned as simplification, in practice it still requires investment in electronic health record systems, workflow redesign, and staff training. For many groups, especially independents, these transitions are costly and disruptive.

 

Physician organizations have raised concerns that increased audit risk and reporting complexity will divert capital and management attention away from patient care and growth initiatives, further tightening margins. For investors, these dynamics increasingly favor operators with scale, payer diversification, and the infrastructure to absorb regulatory and administrative complexity.

 

Real Estate Outlook for 2026

Taken together, the 2026 environment is defined by tightening conditions: reimbursement pressure on specialties, MA-driven volume uncertainty, rising compliance costs, and continued labor and supply inflation. As a result, many providers are expected to slow expansion and prioritize internal cost control.

 

Capital expenditures are likely to focus defensively on systems that improve efficiency or ensure compliance, rather than on new locations. That said, demand for healthcare services remains fundamentally strong. Patient demand is non-discretionary, the population continues to age, and care delivery continues to shift toward outpatient settings. As a result, healthcare real estate fundamentals remain resilient despite near-term reimbursement and operational headwinds.

 

These dynamics support continued strength in healthcare real estate fundamentals, particularly compared to general office. Demand is expected to remain concentrated in well-located outpatient facilities, such as medical office buildings, where supply remains constrained and occupancy is high.

Strengthening the Provider Balance Sheet

Provider balance-sheet pressure may also drive increased sale-leaseback activity. Rather than signaling distress, these transactions are increasingly viewed as strategic liquidity tools that allow providers to unlock embedded real estate equity without disrupting clinical operations. Proceeds are often redeployed into core priorities like staffing, technology upgrades, compliance infrastructure, and service-line optimization, while long-term leases enable providers to retain operational control and location continuity. For investors, this trend supports stable, mission-critical tenancy backed by operators seeking capital efficiency, rather than exit.

 

For investors, understanding how reimbursement policy flows through to provider behavior will be critical to underwriting tenant durability and long-term performance in healthcare real estate.

 

More than ever, working with a medical healthcare CRE expert who deeply understands both the real estate and the underlying provider business is essential. In today’s environment, evaluating a deal goes beyond headline returns and cap rates—it requires assessing operator fundamentals, reimbursement exposure, and operational resilience. Decisions around whether to buy, sell, refinance, or hold are increasingly tied to the success of the tenant’s business, making specialized expertise a critical advantage for investors navigating heightened operational risk.